Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Leuk Res. 2010 Jan 31;34(7):871–876. doi: 10.1016/j.leukres.2010.01.005

Table 2. Statistical comparison of trabecular volume in MPN groups with normal controls (column 2) and primary myelofibrosis patients (column 3).

P value vs. control P value vs. PMF
control ---- <0.0001
PMF <0.0001 ----
ET 0.0015 <0.0001
post-ET MF <0.0001 0.0004
PV 0.0006 <0.0001
post-PV MF <0.0001 0.0725
CML 0.0461 <0.0001
MPN/MDS, MPN-U 0.0014 <0.0001

Control = normal bone marrows from lymphoma staging biopsies; PMF = primary myelofibrosis; ET = essential thrombocythemia; post-ET MF = post - essential thrombocythemia myelofibrosis; PV = polycythemia vera; post-PV MF = post - polycythemia vera myelofibrosis; CML = chronic myelogenous leukemia; MPN/MDS = combined myeloproliferative/myelodysplastic neoplasms and MPN-U = unclassifiable myeloproliferative neoplasms